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Massachusetts Medical School, Worcester, MA 01655; bLaboratory of Cellular and Structural Biology and cLaboratory 
of Mass Spectrometry and Gaseous Ion Chemistry, Rockefeller University, New York, NY 10065; dProteomics and Mass 
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ABSTRACT Cytokinesis, the process by which cytoplasm is apportioned between dividing 
daughter cells, requires coordination of myosin II function, membrane trafficking, and central 
spindle organization. Most known regulators act during late cytokinesis; a few, including the 
myosin II–binding proteins anillin and supervillin, act earlier. Anillin’s role in scaffolding the 
membrane cortex with the central spindle is well established, but the mechanism of supervillin 
action is relatively uncharacterized. We show here that two regions within supervillin affect 
cell division: residues 831–1281, which bind central spindle proteins, and residues 1–170, 
which bind the myosin II heavy chain (MHC) and the long form of myosin light-chain kinase. 
MHC binding is required to rescue supervillin deficiency, and mutagenesis of this site creates 
a dominant-negative phenotype. Supervillin concentrates activated and total myosin II at the 
furrow, and simultaneous knockdown of supervillin and anillin additively increases cell division 
failure. Knockdown of either protein causes mislocalization of the other, and endogenous anil-
lin increases upon supervillin knockdown. Proteomic identification of interaction partners re-
covered using a high-affinity green fluorescent protein nanobody suggests that supervillin and 
anillin regulate the myosin II and actin cortical cytoskeletons through separate pathways. We 
conclude that supervillin and anillin play complementary roles during vertebrate cytokinesis.
INTRODUCTION
Cytokinesis is a dynamic multistep process in which the plasma 
membrane, the actin- and myosin II–associated membrane cortex, 
and components of the microtubule-rich central spindle coordinate 
the physical separation of a dividing cell into daughter cells (recently 
reviewed in Green et al., 2012). As animal cells enter anaphase and 
the central spindle forms, it sends signals that recruit myosin II and 
actin to the cell equator (Werner et al., 2007; Salbreux et al., 2012). 
Ingression of the cleavage furrow requires continued myosin II acti-
vation at the cell equator and remodeling of the cortical actin cy-
toskeleton as the furrow narrows into an intracellular bridge with a 
midbody at its center by telophase (Wang, 2005; D’Avino, 2009). 
The cortex maintains a close association with the central spindle and 
midbody until abscission into daughter cells is complete at the end 
of cytokinesis (Frenette et al., 2012; Green et al., 2012). Successful 
cell division requires coordination of myosin activation, actin cy-
toskeletal proteins, and central spindle assembly with membrane 
trafficking to and from the furrow (Poirier et al., 2012; Salbreux et al., 
2012; Schiel and Prekeris, 2013).
Genetic deletion or RNA interference (RNAi)–mediated knock-
down of several membrane-associated, cytoskeletal proteins leads to 
division failure during early cytokinesis. These proteins include myo-
sin II, citron kinase, epithelial cell transforming sequence 2 oncogene 
(ECT2), epithelial protein lost in neoplasm/LIM domain and actin 
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multinucleated cells (Smith et al., 2010). We show here the rescue of 
that phenotype by expression of enhanced green fluorescent pro-
tein (EGFP)–tagged human supervillin (hSV; Figure 1, A–D). This 
EGFP-hSV message is susceptible to a double-stranded RNA 
(dsRNA) targeting the coding region of hSV (supervillin knockdown 
by specific double-stranded RNA-1 [SVKD-1]) but not to a 3′-un-
translated region UTR (3′UTR)–targeted dsRNA (SVKD-2; Figure 1A, 
lanes 5 and 6). EGFP-hSV could not rescue the knockdown pheno-
type caused by SVKD-1 but reduced to control levels the numbers 
of binucleated/multinucleated cells generated by SVKD-2 (Figure 
1B). Rescue also was observed, with expression levels of EGFP-hSV 
only twofold to threefold higher than that of endogenous protein in 
a stable HeLa cell line (Figure 1, C and D), but not by expression of 
EGFP-tagged bovine supervillin (EGFP–bSV; Figure 1, E and F). Sub-
sequent to this work, we became aware that the EGFP-hSV con-
struct in the stable cell line contains a point mutation (K923E). Nev-
ertheless, both higher levels of wild-type EGFP-hSV (Figure 1, A and 
B) and near-endogenous levels of EGFP-hSV(K923E) (Figure 1, C 
and D) rescued the binucleated/multinucleated phenotype of su-
pervillin-knockdown cells.
Two regions of supervillin, including the myosin II regulatory se-
quence, are important for normal cell division, whereas actin-bind-
ing sequences target supervillin to the furrow. Although full-length 
EGFP-bSV did not rescue the knockdown phenotype, its overex-
pression was not detectably harmful (Figure 1G). We therefore used 
a panel of existing EGFP-bSV deletion mutants to determine 
whether their overexpression would result in dominant-negative 
increases in binucleated/multinucleated cells in the presence of 
endogenous hSV (Figure 1G and Supplemental Figures S1 and S2). 
As compared with EGFP expression alone, cell division was not de-
tectably affected by the expression of bSV-1–171-EGFP or EGFP-
bSV-1010–1792. Expression of EGFP-bSV-1–830, which contains the 
myosin II regulatory sequence plus all three actin-binding sites, 
caused a small but significant decrease in the number of binucle-
ated/multinucleated cells. By contrast, significant twofold or greater 
increases in the percentages of binucleated/multinucleated cells 
were seen upon expression of EGFP-bSV-171–1792, which lacks the 
myosin II/L-MLCK–binding sequence, and after expression of EGFP-
bSV-831–1281, which contains a coiled-coil sequence and binding 
sites for the central-spindle protein KIF14 and other cell-cycle regu-
latory proteins (Wulfkuhle et al., 1999; Smith et al., 2010; Figure 1G, 
red bars). Increases also were observed with other constructs but 
did not pass statistical testing. Consistent with dominant-negative 
effects on cell division, we also observed aberrant nuclear and corti-
cal morphologies in cells expressing constructs that increased the 
numbers of binucleated/multinucleated cells (Supplemental Figure 
S2, q–t′, y–b′′). All constructs that contained the three F-actin–bind-
ing sequences within bSV-171–830 (Chen et al., 2003) were concen-
trated at the furrow (Figure 1G and Supplemental Figure S2). These 
data suggest that although the myosin II/L-MLCK–interacting region 
within bSV-1–170 is not required to target supervillin to the furrow of 
dividing cells, its loss generates a dominant-negative phenotype 
(Figure 1G).
Supervillin is required for normal localization of total and acti-
vated myosin II at the equatorial cortex during cytokinesis (Figure 
2). We previously reported that furrow ingression is disrupted after 
supervillin knockdown and that supervillin promotes myosin II acti-
vation at membranes in interphase cells by scaffolding MHC and 
L-MLCK (Takizawa et al., 2007; Bhuwania et al., 2012). We therefore 
explored whether supervillin knockdown would displace total or 
activated myosin II from the cleavage furrow during early cytokine-
sis (Figure 2), using antibodies against myosin IIA heavy chain 
binding 1 (EPLIN/LIMA1), and two proteins that bind to both myosin 
II and F-actin: anillin and supervillin (Knecht and Loomis, 1987; Field 
and Alberts, 1995; Straight et al., 2005; Zhao and Fang, 2005; 
Chalamalasetty et al., 2006; Gruneberg et al., 2006; Piekny and 
Glotzer, 2008; Chircop et al., 2009; Smith et al., 2010; Watanabe 
et al., 2013). After RNAi-mediated depletion of either anillin or super-
villin, furrows form and begin to ingress, but then the cells contract 
and bleb abnormally around their peripheries, with large movements 
of cytoplasm relative to the cleavage furrow (Straight et al., 2005; 
Zhao and Fang, 2005; Smith et al., 2010). Vertebrate supervillin and 
anillin both bind directly to the myosin II heavy chain (MHC) and can 
bind and bundle actin filaments (Field and Alberts, 1995; Chen et al., 
2003; Straight et al., 2005). Anillin and supervillin also both interact 
with components of the central spindle (Piekny and Glotzer, 2008; 
Smith et al., 2010; Frenette et al., 2012). In addition, supervillin regu-
lates cell proliferation through control of p53 levels (Fang and Luna, 
2013) and contributes to cell motility, invasion, and rapid recycling of 
membrane vesicles (Crowley et al., 2009; Fang et al., 2010; Bhuwania 
et al., 2012). These reports suggest overlapping roles for these pro-
teins in regulation of myosin II and actin assembly at the membrane.
Because vertebrate anillin and supervillin both contain binding 
sites for F-actin, myosin II, and central spindle proteins, we hypoth-
esized that these proteins might play complementary roles in regu-
lating cortex organization relative to the central spindle during early 
cytokinesis. This hypothesis is consistent with the similarity in timing 
of cytokinesis failure after knockdown of either protein (Straight 
et al., 2005; Zhao and Fang, 2005; Smith et al., 2010). Supervillin 
homologues exist in worms and flies but lack N-terminal sequences 
corresponding to the myosin II– and actin-binding sites in verte-
brate supervillins (Pestonjamasp et al., 1997; Pope et al., 1998; 
Archer et al., 2005). Thus, reports that loss of anillin from vertebrate 
cells results in a lower incidence of multinucleated cells than is ob-
served after anillin depletion in Caenorhabditis elegans oocytes and 
Drosophila cells (Echard et al., 2004; Maddox et al., 2005; Straight 
et al., 2005; Zhao and Fang, 2005) may be due to the absence of 
functionalities specific to vertebrate supervillin.
We further hypothesized that, like anillin (Straight et al., 2005; 
Zhao and Fang, 2005; Hickson and O’Farrell, 2008; Piekny and 
Glotzer, 2008), supervillin might promote the localization of acti-
vated, phosphorylated myosin regulatory light chain (pMRLC) to the 
furrow, perhaps through its interactions with the long isoform of 
myosin light chain kinase (L-MLCK; Takizawa et al., 2007; Bhuwania 
et al., 2012). Mice lacking MLCK survive to birth, indicating that this 
protein is dispensable for embryonic cell divisions (Somlyo et al., 
2004), but inhibition of MLCK suggests synergy with other kinases 
during divisions leading to polyploid megakaryocytes (Avanzi et al., 
2012). L-MLCK localizes to the cleavage furrow in vertebrates 
(Poperechnaya et al., 2000), and overexpression of the supervillin-
binding L-MLCK N-terminus disrupts cytokinesis (Dulyaninova et al., 
2004). We therefore investigated whether supervillin and anillin co-
operate during cell division and the role of supervillin and its ability 
to bind MHC and L-MLCK in this process. We used HeLa cells, in 
which p53 levels are kept low by papilloma virus proteins in a super-
villin-independent pathway (Li et al., 2004; Fang and Luna, 2013), to 
focus on the role of supervillin’s MHC-binding activity during early 
cytokinesis and how supervillin coordinates with anillin to maintain 
alignment of the cortical cytoskeleton with the central spindle.
RESULTS
Supervillin regulates myosin II in cell division
We showed previously that the knockdown of supervillin in HeLa 
cells leads to a significant increase in the number of binucleated and 
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to GST–myo-S2, but deletion of the first two conserved domains 
either maintained or enhanced binding (Figure 3, A and B, lanes 6 
and 7), suggesting the importance of the third conserved region 
(bSV99–153) for MHC binding. Point mutagenesis of R107/Y108, 
R112/R113, R140/K141, and K148/R149 within bSV99–153 also 
eliminated binding to MHC (Figure 3, C, lanes 5–8, and D, lanes 6 
and 7). Binding to GST–myo-S2 was also reduced for bSV-11–174 
(Figure 3, A, B, lane 5, and C, lane 4), suggesting that the first con-
served region contributes to the binding avidity. However, point 
mutations within the first two conserved domains did not detectably 
affect binding to GST–myo-S2 (Figure 3, D, lanes 3–5, and E, lanes 
4 and 5).
Results from the GST–L-MLCK pull-down assays showed that the 
MHC-binding sequence is not required for the interaction with 
L-MLCK (Figure 3A and Supplemental Figure S5). EGFP-bSV-1–101, 
which lacks the MHC-binding domain, interacts with GST–L-MLCK 
(Supplemental Figure S5A, lane 4), and mutations in SV99–153 had 
no effect on the GST–L-MLCK interaction (Supplemental Figure S5, 
C, lane 5, and D, lane 6). Interaction with GST–L-MLCK is lost by 
further deletion of the second domain (EGFP-bSV-1–23; Supple-
mental Figure S5A, lane 3), but no mutations made in the first two 
conserved domains eliminated the interaction (Supplemental Figure 
S5, B, lane 3, C, lanes 3 and 4, and D, lane 4). We considered the 
possibility that myosin IIA might be acting as a bridge between 
GST–L-MLCK and bSV-1–174-EGFP in the pull-down assays, thereby 
masking the effectiveness of the point mutants. However, the GST-
tagged L-MLCK bait lacks the MHC-binding site in the L-MLCK 
C-terminus, and endogenous MHC is absent from relevant bound 
fractions (Supplemental Figure S5E). These results show that our as-
say design precluded recovery of significant amounts of the ternary 
complex of bSV-1–174 with MHC and L-MLCK. They also show that 
the L-MLCK interaction site within the supervillin N-terminus is dis-
tinct from the binding site for MHC.
The sequences within supervillin investigated here are highly con-
served among vertebrates (Figure 3F). The first conserved region 
within bSV1–174 contributes to, but is not required for, binding to 
both MHC and L-MLCK. The second conserved region may be part 
of a larger site involved in L-MLCK binding. The first and third se-
quences are both required for supervillin-induced myosin II hyper-
contractility (Figure 3A, black bars, and Supplemental Figure S3). The 
third conserved domain also is essential for binding to MHC, with 
numerous point mutations (Figure 3F, brackets labeled M), support-
ing the results of deletion analyses. Because the R140A,K141A muta-
tion effectively abolished both MHC binding and the generation of 
hypercontractile punctae in the COS7 experiments (Figure 3, A and 
C, and Supplemental Figure 4), we chose it for further experiments.
Myosin II binding is important for supervillin function 
during cell division
Supervillin proteins with point mutations at the MHC-binding site 
exhibit dominant-negative effects on cell division and are unable to 
rescue the supervillin-knockdown phenotype (Figure 4). To further 
test the requirement of the supervillin–myosin II interaction for cy-
tokinesis, we transferred point mutations into full-length EGFP-bSV 
and repeated the assay for dominant-negative effects on cell division 
in the presence of endogenous supervillin, using EGFP alone and 
bSV-171–1792 as controls (Figure 4A). Point mutations in the first 
two conserved domains did not significantly affect the percentages 
of binucleate/multinucleate cells (Figure 4A; K4A, R6A, R9A, R10A 
and E36A, E37A). By contrast, the R140A,K141A mutation, which 
eliminated MHC binding in vitro and in vivo (Figure 3 and Supple-
mental Figure S4), was as effective as bSV-171–1792 at inducing a 
(Figure 2A), the major myosin II isoform in HeLa cells (Maupin et al., 
1994), and against phosphorylated Ser-19 in myosin II regulatory 
light chain (pMRLC; Figure 2B; Matsumura et al., 1998). MHC ap-
pearance was indistinguishable from controls through anaphase I 
(unpublished data). However, compared with controls (Figure 2A, 
a–d, i–l), myosin II concentrations at the polar cortices increased in 
supervillin-knockdown cells starting in anaphase II (Figure 2A, e–h, 
arrowhead) and remained mislocalized through bridge formation 
(Figure 2A, m–p, arrowheads), resulting in significantly decreased 
ratios of equatorial-to-polar signals (Figure 2C, red vs. blue 
regions).
Of interest, the effects of supervillin knockdown on pMRLC local-
ization (Figure 2, B and D) did not follow the same pattern as the 
effects on total myosin II. Compared to controls (Figure 2B, a–d, i–l), 
activated myosin II was mislocalized in supervillin-depleted cells in 
anaphase I (Figure 2B, e–h), regained the expected localization to 
the invaginating furrow in anaphase II and telophase (Figure 2D), 
and then became mislocalized again during bridge formation 
(Figure 2, B, m–p, D). These results suggest that supervillin is re-
quired to restrict both total and activated myosin II to the furrow 
during cell division but is not solely responsible for localizing acti-
vated myosin.
Identification of the separate myosin II– and 
L-MLCK–binding sites
Separate sequences within the supervillin N-terminus interact with 
myosin II and the L-MLCK N-terminus (Figure 3 and Supplemental 
Figures S3–S5). Our laboratory showed previously that the N-termi-
nal 174 amino acids of bSV (bSV-1–174) associate with myosin IIB in 
stress fibers in COS7 cells and cause myosin II to contract into stable 
punctae containing bSV-1–174-EGFP, MHC, and L-MLCK (Takizawa 
et al., 2007). We used this system as a first assay for the importance 
of three well-conserved sequences within bSV-1–174 (Figure 3A, 
black bars, and Supplemental Figures S3 and S4). As previously 
shown, cells expressing EGFP alone (Supplemental Figure S3, a–c) 
displayed normal stress fibers, whereas cells expressing bSV-1–174 
tagged with EGFP on either terminus contained punctae of MHC 
and EGFP (Supplemental Figure S3, d–i). These hypercontractile 
punctae were eliminated by deletion of either the N-terminal 11 
residues or C-terminal 47 amino acids of bSV-1–174 (Figure 3A and 
Supplemental Figure S3, j–x) and reduced in cells expressing bSV-
93–174-EGFP (Supplemental Figure S3, y–a′). Point mutations made 
in the first two conserved regions had no detectable effect (Supple-
mental Figure S4, a–o), but charge-to-alanine replacements in the 
third conserved region (bSV-99–153) either reduced or eliminated 
the punctae (Supplemental Figure S4, p–x and y–a′, respectively). 
Taken together, these results implicate the first and third of the three 
highly conserved sequences within bSV1–174 in supervillin-induced 
myosin II hypercontractility (Figure 3A).
Our second approach to identifying interaction sites within bSV-
1–174 was to sediment EGFP-tagged mutated bSV-1–174 proteins 
with glutathione S-transferase (GST) fusion proteins containing ei-
ther the subfragment-2 domain of myosin IIA (GST–myo-S2; Figure 
3, B–E) or the N-terminal six immunoglobulin (IgG)-like domains of 
the long isoform of myosin light-chain kinase (GST–L-MLCK; Sup-
plemental Figure S5, A–D). Our laboratory previously showed that 
GST-bSV-1–174, but not GST alone, binds directly to myosin IIA and 
IIB S2 domains and to the L-MLCK N-terminus (Chen et al., 2003; 
Takizawa et al., 2007). In this assay, EGFP-tagged bSV-1–174 bound 
to each GST construct, as expected (Figure 3, A and B, lane 2, and 
Supplemental Figure S5A, lane 2). C-terminal deletion of bSV-128–
174 (Figure 3, A, B, lanes 4 and 5, and C, lane 3) eliminated binding 
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FIGURE 1: Overexpressed EGFP-hSV, but not EGFP-bSV, rescues the increase in binucleated/multinucleated cells 
caused by knockdown of supervillin; key roles for residues 1–171 and 831–1281 are suggested by dominant-negative 
effects of EGFP-bSV deletion proteins. (A) Immunoblots showing knockdown of endogenous supervillin and 
overexpression of EGFP-hSV; actin used as loading control. Lanes 1–3, EGFP with control (1), SVKD-1 (2), or SVKD-2 
(3) dsRNAs; lanes 4–6, EGFP-hSV with control (4), SVKD-1 (5), or SVKD-2 (6) dsRNAs. (B) Quantification of 
binucleated/multinucleated HeLa cells simultaneously transfected with EGFP (black bars) or EGFP-hSV (gray bars) and 
dsRNAs, as indicated. EGFP-hSV is immune to the SVKD-2 dsRNA. Means ± SD; N = 3; *p = 0.0424 (paired two-tailed 
t test). (C) Immunoblots and (D) quantification of binucleated/multinucleated HeLa cells stably expressing EGFP-
hSV(K923E) after transfection with 20 nM dsRNAs, as indicated. Means ± SD; N = 4; *p = 0.0103, **p = 0.0025 (paired 
two-tailed t test). (E) Immunoblots and (F) quantification of binucleated/multinucleated HeLa cells cotransfected with 
EGFP constructs and either control or SVKD-2 dsRNA, as indicated in E. Means ± SD; N = 4, >50 cells counted per 
condition per experiment; *p < 0.05, **p < 0.01, ***p < 0.001 (analysis of variance [ANOVA]). (G) Fold increase 
(dominant-negative effect) of binucleated/multinucleated HeLa cells after expression of the indicated EGFP-tagged 
bSV deletion mutants for 48 h (representative images in Supplemental Figure S1) and the localizations of these 
proteins during cell division (Supplemental Figure S2). Columns show means ± SD, relative to EGFP-transfected cells; 
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FIGURE 2: Supervillin is required for localization of myosin II at the cytokinetic furrow. (A, B) Immunofluorescence 
localizations of (A) total MHC and (B) regulatory myosin II light chain phosphorylated at Ser-19 (pMRLC, active myosin II) 
in synchronized HeLa cells transfected with control (a–d, i–l) or supervillin-specific (SVKD-2; e–h, m–p) dsRNA. MHC or 
pMRLC signal (a, e, i, m; green in merges); F-actin (b, f, j, n; red in merges), DNA (c, g, k, o; blue in merges) in dividing 
cells. White arrowheads, MHC and pMRLC localizations. Bars, 10 μm. (C, D) Mean ratios of cortex-specific equatorial 
(red) to polar (blue) total (C) and activated myosin II (D) signals in cells at different stages; *p = 0.0483, **p = 0.0058, 
***p ≤ 0.0007 (two-tailed t test). Black bars, control cells; white bars, SVKD-2 cells. Number of cells analyzed was as 
follows: (C) anaphase I (N = 8 control, 13 SVKD), anaphase II (N = 12 control, 11 SVKD), telophase (N = 13 control, 
23 SVKD), and cytokinesis (N = 29 control, 30 SVKD), N = 2 experiments; and (D) anaphase I (N = 15 control, 13 SVKD), 
anaphase II (N = 19 control, 24 SVKD), telophase (N = 13 control, 30 SVKD), and cytokinesis (N = 38 control, 44 SVKD), 
N = 5 experiments.
total numbers of cells and experiments; and localizations of deletion proteins in dividing cells. Red boxes denote 
statistically significant effects on cell division (p ≤ 0.05, two-tailed t test). Red brackets, regions implicated as 
important for cytokinesis, either when absent (bSV1–171) or overexpressed (bSV831–1281). Supervillin domains are 
shown as (white) the intrinsically disordered N-terminus (Fedechkin et al., 2013), (purple) the central region with a 
predicted coiled-coil domain (Wulfkuhle et al., 1999), (blue) five sequences with homology to gelsolin repeats 
(Pestonjamasp et al., 1997), and (gray) the C-terminus with structural similarity to the villin headpiece (Vardar et al., 
2002).
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FIGURE 3: Deletion and point mutagenesis of the myosin II–binding site. (A) Summation of results with EGFP-tagged 
deletion and point mutants of bovine SV1–174 obtained from in vivo overexpression experiments in COS7 cells 
(hypercontractile myosin punctae; Supplemental Figures S3 and S4) and from pull-down experiments with GST-tagged 
myosin II S2 (GST–myo-S2) or GST-tagged L-MLCK N-terminus (GST–L-MLCK; Supplemental Figure S5). Highly 
conserved regions in SV1–174 are indicated in black. White asterisks show approximate locations of point mutations. 
(B–E) Representative anti-GFP immunoblots of bound and unbound GFP-tagged SV1–174 mutant proteins, as indicated, 
after pull down with GST–myo-S2. Ratios show the bound-to-unbound GFP signals as a fraction of the SV1–174-EGFP 
signal (positive control). N ≥ 2. Ratios ≤0.5 were considered binding reductions (A, reduced) and ratios ≤0.1 as no 
binding to myosin II (A, no). Ponceau-stained blots of bound proteins show levels of GST–myo-S2. (F) Sequences of 
highly conserved regions within supervillin amino acids 1–174. Amino acid sequences from human (Homo sapiens, 
NP_003165), cow (Bos taurus, NP_776615), mouse (Mus musculus, ADP02396.1), chicken (Gallus gallus, XP_418577.3), 
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either control or anillin-specific dsRNAs and a plasmid encoding ei-
ther EGFP alone or EGFP-hSV (Figure 5, E and F); we also used the 
HeLa cell line that stably expresses EGFP-hSV(K923E) (unpublished 
data). In both cases, the percentages of binucleate cells upon anillin 
knockdown were unaffected by the overexpression of supervillin 
(Figure 5E). Knockdown of anillin and expression of both EGFP and 
EGFP-hSV were confirmed by Western blot (Figure 5F). We also 
made several attempts at the reciprocal experiment, to rescue su-
pervillin knockdown by overexpression of EGFP-anillin, but were 
unsuccessful due to an apparent loss of substrate adhesion by cells 
expressing EGFP-anillin for >24 h. In this context, we note that the 
nearly twofold increase of endogenous anillin that occurs in super-
villin-knockdown cells (Figure 5D) is insufficient to fully block the ef-
fects of supervillin knockdown (Figure 5C). However, partial com-
pensation by increased anillin may explain why the binucleate/
multinucleate phenotype caused by knockdown of supervillin alone 
dominant-negative defect in cytokinesis (Figure 4A). We then 
performed rescue experiments after mutating the same myosin II–
affecting residues in the full-length EGFP-tagged human supervillin 
(Figure 4B). Wild-type supervillin (EGFP-hSV) again rescued the 
knockdown phenotype, but two mutants defective in binding to 
MHC (R140A,K141A; K148A,R149A; Figure 3C, lanes 7 and 8) failed 
to return the numbers of binucleate/multinucleate cells to control 
levels. Although these experiments do rule out a role for the super-
villin interaction with L-MLCK during cytokinesis, they show that the 
interaction with myosin II is critical for normal cell division.
Supervillin and anillin play nonredundant roles 
in cell division
Supervillin and anillin are both required for high-fidelity production 
of daughter cells (Figure 5). The phenotypes observed upon super-
villin knockdown are similar to that of another cortical cell division 
protein, anillin, which also is required for the localization of total and 
active myosin II at the cleavage furrow (Straight et al., 2005; Zhao 
and Fang, 2005). Although their amino acid sequences are very dif-
ferent, supervillin and anillin exhibit a similar organization of interac-
tion domains: both bind directly to myosin II and F-actin, contain 
functional nuclear targeting sequences (Figure 5A, black T), and are 
predicted to have a central coiled-coil domain (Figure 5A, blue bars; 
Pope et al., 1998; Wulfkuhle et al., 1999; Oegema et al., 2000; Chen 
et al., 2003; Straight et al., 2005; Piekny and Glotzer, 2008). Both 
also bind to proteins in the central spindle: anillin to citron kinase, 
RhoA, and the RhoA guanine nucleotide exchange factor ECT2 
(Piekny and Glotzer, 2008; Gai et al., 2011; Frenette et al., 2012), 
and supervillin to the kinesin KIF14 and to protein regulator of cy-
tokinesis 1 (PRC1; Zhu et al., 2005; Carleton et al., 2006; Gruneberg 
et al., 2006; Smith et al., 2010; Hasegawa et al., 2013). In addition, 
the supervillin C-terminus binds to the furrow-regulatory protein, 
EPLIN (Chircop et al., 2009; Smith et al., 2010). To determine the 
relationship between supervillin and anillin during cell division, we 
first quantified the effects on HeLa cell division after single and dou-
ble knockdowns of these two proteins. The numbers of binucleated/
multinucleated cells increased significantly (Figure 5, B, white ar-
rowheads, and C) after the knockdown of either supervillin alone 
(Figure 5B, b, SVKD) or anillin alone (Figure 5, B, c and e; anillin 
knockdown by specific double-stranded RNA-1 [AnilKD-1], 
AnilKD-2), as compared with treatment with control dsRNA (Figure 
5, B, a, and C). Knockdown efficiency (Figure 5D) and percentage 
increase in number of binucleated cells for single knockdowns were 
similar to those reported previously (Straight et al., 2005; Zhao and 
Fang, 2005; Smith et al., 2010). Supervillin levels were unaffected by 
anillin knockdown, but surprisingly the amount of endogenous anil-
lin increased an average of (1.9 ± 0.3)-fold (both dsRNAs, n = 11; 
p < 0.0001, t test) after supervillin knockdown (Figure 5D, lane 2). 
Simultaneous knockdown of supervillin and anillin approximately 
doubled the percentages of binucleated/multinucleated cells as 
compared with either single knockdown, with up to ∼80% of cells 
failing cytokinesis (Figure 5, B, d and f, and C). These effects were 
more than additive, consistent with effects in parallel pathways.
We next asked whether overexpression of EGFP-hSV could res-
cue the binucleate phenotype caused by knockdown of anillin 
(Figure 5, E and F). We simultaneously transfected HeLa cells with 
FIGURE 4: Point mutations that disrupt binding to myosin II mimic 
the dominant-negative phenotype of bSV171–1792 and eliminate 
rescue of the binucleate/multinucleate phenotype by full-length 
human EGFP-SV. (A) Dominant-negative overexpression of EGFP-bSV 
constructs. Cells were assayed as in Figure 1G. Means ± SD; N ≥ 3 
experiments; >30–151 cells per condition per experiment. *p = 
0.0228, **p = 0.0055 (paired two-tailed t test). (B) Lack of rescue of 
the binucleate/multinucleate phenotype in SVKD cells by EGFP-hSV 
proteins containing point mutations that eliminate myosin II binding 
(hSV-R140A,K141A; hSV-K148A,R149A). Mean percentages of 
binucleate/multinucleate cells ± SD; N ≥ 3 experiments; ≥60 cells 
counted per condition per experiment. **p < 0.01, ***p < 0.001 
(ANOVA).
and frog (Xenopus (Silurana) tropicalis, NP_001090765.1) supervillins were aligned using CLUSTALW 2.1 (www.genome 
.jp/tools/clustalw/). Brackets, residues targeted for alanine or phenylalanine replacement, as described in Materials and 
Methods. L, the four-residue mutation that reduced the L-MLCK interaction; M, mutations that reduced or eliminated 
myosin II interaction. **Point mutation used in subsequent assays.
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Overlapping cytoskeletal interactors but distinct signaling 
proteins
Protein affinity isolations suggest overlapping cytoskeletal partners 
and distinct signaling pathways for supervillin and anillin (Table 1). 
We used a high-affinity anti-GFP nanobody on magnetic beads 
(Domanski et al., 2012) to collect complexes from extracts of HeLa 
cells that were transfected for 24 h with EGFP alone, EGFP-tagged 
hSV, or EGFP-tagged anillin. Cultures were enriched for dividing 
cells by treating with a Cdk1 inhibitor to synchronize them at the 
G2/M boundary; unsynchronized cells were used for comparison. 
Bead-associated proteins were eluted and identified by mass spec-
trometry using stringent criteria for protein assignments. The most 
abundant interacting proteins specific for supervillin and anillin are 
shown in Table 1. Nonspecific contaminants were defined as pro-
teins that were represented by total spectral peptide counts in the 
EGFP-only samples that were ≥50% of those observed in the EGFP-
supervillin or EGFP-anillin samples (Supplemental Table S2). The 
majority of these contaminants were skin epithelial proteins, but 
they included abundant proteins from many intracellular compart-
ments. All proteins specifically recovered with GFP nanobody beads 
from M-phase–enriched and unsynchronized cells are listed in Sup-
plemental Tables S3 and S4, respectively. Although supervillin and 
anillin did not appreciably coisolate with each other, myosin II was 
the most abundant specific interactor for each, with both the myosin 
IIA heavy chain (MYH9) and light chains well represented (Table 1). 
Actin and actin-binding proteins, such as filamin A, also are abun-
dant in the pull downs for both proteins.
Additional known interactors for each protein are well repre-
sented in our affinity isolations (Table 1). These include the supervil-
lin interactors, EPLIN, KIF14, and 14-3-3 proteins (Jin et al., 2004; 
Smith et al., 2010). All three of these proteins participate in signaling 
pathways that, like supervillin, regulate both cell motility and cytoki-
nesis (Carleton et al., 2006; Gruneberg et al., 2006; Han et al., 2007; 
Chircop et al., 2009; Zhou et al., 2010; Freeman and Morrison, 2011; 
Ahmed et al., 2012). Anillin-specific interacting proteins include 
CD2AP, SH3KBP1/CIN85/Cindr, and citron Rho-interacting kinase 
(Table 1; Monzo et al., 2005; Haglund et al., 2010; Gai et al., 2011). 
CD2AP and SH3KBP1 are SH3 domain–containing proteins that par-
ticipate in membrane trafficking and actin remodeling, as well as 
cytokinesis (Monzo et al., 2005; Havrylov et al., 2008; Johnson et al., 
is less penetrant than that seen in anillin-depleted cells (Figure 5C) 
and raises the possibility of intersecting pathways.
Supervillin is mislocalized in dividing cells depleted of anillin. To 
determine where and when supervillin and anillin pathways might 
cross-talk during cell division, we first used the HeLa stable cell line 
from Figure 1D to quantify supervillin localization in cells depleted 
of anillin (Figure 6). Consistent with our previous observation with 
bovine supervillin (Smith et al., 2010), human supervillin concen-
trated at the cleavage furrow in cells treated with control dsRNA 
(Figure 6A, a–h′). The equatorial-to-polar ratio of supervillin in these 
control cells increased during anaphase II and telophase, dropping 
somewhat at bridge formation (Figure 6B, black bars). By contrast, 
anillin knockdown mislocalized supervillin away from the cleavage 
furrow by anaphase II (Figure 6A, i–p′ and q–x′, white arrowheads), 
as represented by a relatively constant equatorial-to-polar ratio of 
supervillin signals throughout cell division (Figure 6B, gray and white 
bars). Note that anillin-depleted cells generally do not progress past 
anaphase II before furrowing fails (Straight et al., 2005; Zhao and 
Fang, 2005), making it impossible to determine whether supervillin 
can be recruited to the membrane around the midbody in late cy-
tokinesis (Smith et al., 2010) after anillin knockdown.
Anillin localization is independent of supervillin from anaphase 
through telophase (unpublished data) but becomes mislocalized in 
supervillin-knockdown cells away from the midbody and into the 
cortices of the bridge and nascent daughter cells (Figure 7). Consis-
tent with previous reports (Field and Alberts, 1995; Oegema et al., 
2000), anillin concentrates at the center of the midbody within the 
cytokinetic bridge in dividing HeLa cells treated with control dsRNA 
(Figure 7, A, a–d′, white arrowheads, and B, red box). However, in 
supervillin-knockdown cells, anillin became redistributed away from 
the midbody into the cortices of the daughter cells at the proximal 
ends of the cytokinetic bridge (Figure 7, A, e–h′ and i–l′, white ar-
rowheads, and B, blue region). This aberrant anillin signal is reminis-
cent of both the supervillin (Smith et al., 2010) and myosin II (Figure 
2Ai) localizations in control cells at this stage of cell division. This 
localization also resembles that observed for anillin after knockdown 
of the central spindle component citron kinase (Gai et al., 2011). 
Taken together with the mislocalization of supervillin upon loss of 
anillin (Figure 6), these results suggest compensatory pathways that 
may cross-talk to regulate myosin II activity during cell division.
FIGURE 5: Supervillin (SV) and anillin synergistically regulate cell division, but supervillin overexpression does not rescue 
anillin knockdown. (A) Similar organization of binding sites in supervillin and anillin. Both proteins bind directly to myosin 
II (pink), bind and bundle F-actin (orange), and contain nuclear localization signals (black T’s) and coiled-coil domains 
(dark blue). Both bind central spindle proteins: supervillin to PRC1 and KIF14, which also binds citron kinase; and anillin 
to citron kinase, RhoA, and the Rho guanine nucleotide exchange factor ECT2. The supervillin N-terminus also binds to 
L-MLCK, and its C-terminus interacts with EPLIN/LIMA1, another cytokinetic regulator. Gelsolin homology repeats 
(yellow); villin-like headpiece (black bar); anillin homology region (AH, green); PH domain (cyan). (B) Representative 
micrographs of each knockdown condition showing binucleated/multinucleated HeLa cells (white arrowheads). 
(a) Control, (b) control + SV knockdown (SVKD-2), (c) control + anillin knockdown 1 (AnilKD-1), (d) SVKD-2 + AnilKD-1, 
(e) control + anillin knockdown 2 (AnilKD-2), and (f) SVKD-2 + AnilKD-2. Actin shown in red, DNA in blue. Bar, 20 μm. 
(C) Percentages of cells with two or more nuclei 48 h after transfection with control, supervillin-specific, or anillin-specific 
dsRNAs. Means ± SD, n > 250 cells counted per condition per experiment; N = 3 experiments; *p < 0.05 (paired 
two-tailed t test). (D) Immunoblots of HeLa lysates showing supervillin and anillin knockdowns (20 nM total dsRNA), with 
actin as loading control. Numbers indicate the mean residual percentages of supervillin and anillin after 48 h of 
knockdown, N = 4. Endogenous anillin levels consistently increased at 48 h in supervillin-knockdown cells. Lanes: 1, 
control dsRNA; 2, control + SVKD-2; 3, control + AnilKD-1; 4, control + AnilKD-2; 5, SVKD-2 + AnilKD-1; 6, SVKD-2 + 
AnilKD-2. (E) Quantification of binucleated/multinucleated HeLa cells simultaneously transfected with EGFP (black bars) 
or EGFP-hSV (gray bars) and anillin dsRNAs, as indicated. Means ± SD; N = 3 experiments, >46–143 cells counted per 
condition per experiment. (F) Immunoblots showing overexpression of EGFP-hSV and knockdown of anillin; actin used 
as loading control. Anti-GFP confirms expression of EGFP and EGFP-hSV. Lanes 1–3, EGFP with control (1), Anil KD-1 
(2), or Anil KD-2 (3) dsRNAs; lanes 4–6, EGFP-hSV with control (4), Anil KD-1 (5), or Anil KD-2 (6) dsRNAs.
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2008; Samoylenko et al., 2012), and citron kinase regulates cytoki-
nesis through its interactions with Rho and KIF14 (Gruneberg et al., 
2006; Watanabe et al., 2013). The presence of citron kinase in only 
the isolates from synchronized EGFP-anillin cells suggests that the 
enrichment for M-phase cells was effective. By contrast, supervillin-
interacting proteins appear to be largely the same in interphase ver-
sus M-phase and include many proteins (α-actinin, capping protein, 
tropomyosin, tropomodulin) associated with stress fibers and other 
unbranched actin filaments.
Many new candidate interactors for supervillin and anillin also 
were revealed (Table 1 and Supplemental Tables S3 and S4). Novel 
direct or indirect interactors for supervillin include four membrane-
associated myosins (myosins 1B, 1C, 6, and 18A), suggesting addi-
tional loci for cross-regulation of membrane dynamics and furrow 
structure. Supervillin family members flightless-1 and gelsolin also 
emerged as supervillin-selective interactors (Table 1). Flightless-1 
FIGURE 6: Supervillin remains at the furrow during initial stages of 
division in anillin-knockdown cells but becomes mislocalized in late 
anaphase. (A) HeLa cells stably expressing EGFP-hSV(K923E) were 
transfected with either control (a–h′) or one of two anillin-specific 
dsRNAs (i–x′), and stained with anti-EGFP (a, e, i, m, q, u; green in 
merge), actin (b, f, j, n, r, v; red in merge), and DNA (c, g, k, o, s, w; 
blue in merge). Phase images shown in d′, h′, l′, p′, t′, x′. Bar, 10 μm. 
Supervillin is initially present at the invaginating furrow in dividing 
cells but becomes mislocalized around the cortex beginning in 
anaphase II in anillin-knockdown cells (white arrowheads in e, i, m, q, 
u). (B) Ratio of cortex-specific equatorial-to-polar SV signal in cells at 
indicated stages of cell division, calculated as in Figure 2; **p < 0.01, 
***p < 0.001 (ANOVA). Black bars, control cells; gray bars, AnilKD-1 
cells; white bars, AnilKD-2 cells. Numbers of cells analyzed at each 
stage, combined from two different experiments: anaphase I (N = 7 
control, 13 Anil1, 6 Anil2), anaphase II (N = 8 control, 16 Anil1, 
15 Anil2), telophase (N = 5 control, 12 Anil1, 15 Anil2), and cytokinesis 
(N = 23 control, 22 Anil1, 11 Anil2).
FIGURE 7: Anillin is mislocalized away from the midbody into the 
cortex during cytokinesis in supervillin-knockdown cells. (A) HeLa cells 
transfected with control (a–d′) or supervillin-specific (SVKD-1, e–h′; 
SVKD-2, i–l′) dsRNAs and stained for endogenous anillin (a, e, i; green 
in merge), actin (b, f, j; red in merge), and DNA (c, g, k; blue in merge). 
Phase images shown in d′, h′, l′. Bar, 10 μm. Anillin localization at the 
midbody and cytokinetic furrow shown by white arrowheads (a, e, i). 
(B) Ratio of anillin signal in the midbody (red box) vs. the cortices of 
the daughter cells proximal to the furrow (blue). Mean ratios ± SD; 
N = 3 experiments; **p = 0.0019 (two-tailed t test). Total number of 
cells assayed: 34 control (black bar) and 77 SVKD (white bar).
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Protein
Total spectral counts (minus background)
M phase Unsynchronized Known interactors
SVIL ANLN SVIL ANLN Supervillin Anillin
Myosin II
Myosin-9, MYH9 1480 180 1449 515 Chen et al. (2003) Straight et al. 
(2005)
Myosin regulatory light chain 12A, 
MYL12A
55 6 67 21
Myosin light polypeptide 6, MYL6 33 3 46 6
Myosin regulatory light polypeptide 9, 
MYL9
39 0 41 0
Baits
Supervillin, SVIL 993 0 2182 0
Anillin, ANLN 11 1300 7 1946
Other myosins
Unconventional myosin-Ic, MYO1C 156 10 209 47
Unconventional myosin-Ib, MYO1B 154 5 200 29
Unconventional myosin-VI, MYO6 150 1 214 15
Unconventional myosin-XVIIIa, MYO18A 100 0 30 0
Actin and actin-binding proteins
Actin, cytoplasmic 2, ACTG1 603 49 1175 148
Actin, cytoplasmic 1, ACTB 607 68 1175 164 Chen et al. (2003) Field and Alberts 
(1995)
Filamin-A, FLNA 80 65 110 19 Smith et al. (2010)
α-Actinin-4, ACTN4 117 14 161 33 Nebl et al. (2002)
α-Actinin-1, ACTN1 71 12 96 15 Nebl et al. (2002)
F-actin-capping protein subunit α-1, 
CAPZA1
86 34 124 106
F-actin-capping protein subunit α-2, 
CAPZA2
51 14 58 51
F-actin-capping protein subunit β, 
CAPZB
87 17 99 114
Coronin-1C, CORO1C 82 8 135 23
Drebrin, DBN1 81 0 49 9
Protein flightless-1 homologue, FLII 48 0 33 0
Gelsolin, GSN 30 1 8 0
LIM domain and actin-binding protein 1, 
LIMA1/EPLIN
25 0 82 0 Smith et al. (2010)
Tropomyosin α-1 chain, TPM1 40 0 33 5
Tropomyosin β chain, TPM2 34 0 25 4
Tropomyosin α-3 chain, TPM3 42 0 30 5
Tropomyosin α-4 chain, TPM4 46 4 38 5
Tropomodulin-3, TMOD3 35 0 52 0
Other cytoskeletal proteins
Kinesin-like protein KIF14, KIF14 89 0 212 0 Smith et al. (2010)
Tubulin α-4A chain, TUBA4A 25 52 0 0
TABLE 1: Most abundant specific interactors with GFP-tagged supervillin and anillin. 
 Continues
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partners between supervillin and anillin suggest that these proteins 
participate in distinguishable pathways that overlap to regulate my-
osin II function at the furrow.
DISCUSSION
We show here that the MHC-binding site within supervillin lies within 
residues 99–153 and that loss of myosin II binding leads to domi-
nant-negative disruption of cell division and loss of ability to rescue 
supervillin depletion. Point mutagenesis suggests that at least five 
regions of local charge are involved in the supervillin–MHC interac-
tion. Supervillin residues 93–125 were previously implicated in bind-
ing to myosin II by proteolytic mapping (Chen et al., 2003) and are 
unstructured although predicted to be capable of ligand-dependent 
folding (Meszaros et al., 2009; Fedechkin et al., 2013). Supervillin 
amino acids 1–10 also contribute to binding avidities for both MHC 
and L-MLCK, although they are not sufficient for binding to either 
protein. These residues may be part of secondary, lower-avidity in-
teractions for each protein or be important for ligand-dependent 
structural rearrangements that facilitate tight binding.
We also show here that supervillin binding to myosin II is required 
for efficient cytokinesis; that this phenotype is similar to, but occurs 
promotes Rho-induced activation of linear actin assembly by form-
ins (Higashi et al., 2010), and gelsolin may directly regulate myosin 
II activity at cell–substrate adhesions through calcium-dependent 
binding to MHC (Arora et al., 2013). Other supervillin-selective inter-
actors are the signaling proteins IQGAP1, PRKDC, and MPRIP/
p116Rip. IQGAP1 is a large multidomain protein that regulates nu-
merous motile processes, including cytokinesis (Shannon, 2012). 
PRKDC is a large member of the phosphoinoside-3/phosphoino-
side-4 kinase family that has been primarily studied for its role in 
DNA repair and p53-mediated apoptosis after exposure to ionizing 
radiation but also has been implicated in mitotic progression 
(Stephan et al., 2009; Hill and Lee, 2010). Although it is not known 
to regulate cytokinesis, MPRIP recruits myosin phosphatase to un-
branched actin filaments and thus regulates pMRLC activation (Koga 
and Ikebe, 2005; Surks et al., 2005). Conversely, serine/threonine 
protein phosphatase 2A emerged as a novel candidate interactor 
for anillin (Table 1); homologues of this protein regulate myosin II 
assembly or cytokinesis in yeast and soil amoeba (Rai and Egelhoff, 
2011; Goyal and Simanis, 2012). Thus, most of the newly identified 
abundant interactors are known or plausible participants in cytoki-
netic signaling pathways. The reproducible differences in interaction 
Protein
Total spectral counts (minus background)
M phase Unsynchronized Known interactors
SVIL ANLN SVIL ANLN Supervillin Anillin
Tubulin α-1C chain, TUBA1C 25 74 0 0
Signaling proteins
14-3-3 protein epsilon, YWHAE 63 5 69 0 Jin et al. (2004)
14-3-3 protein gamma, YWHAG 31 0 51 0 Jin et al. (2004)
Ras GTPase-activating-like protein 
IQGAP1
45 9 68 4
DNA-dependent protein kinase catalytic 
subunit, PRKDC
31 2 14 0
Myosin phosphatase Rho-interacting 
protein, MPRIP
27 0 24 0
CD2-associated protein, CD2AP 0 56 0 225 Monzo et al. 
(2005)
SH3 domain-containing kinase-binding 
protein 1, SH3KBP1/CIN85/Cindr
0 25 0 157 Haglund et al. 
(2010)
Ser/Thr-protein phosphatase 2A regula-
tory subunit A α, PPP2R1A
6 20 14 21
Ser/Thr-protein phosphatase 2A regula-
tory subunit B α, PPP2R2A
6 20 13 18
(Citron Rho-interacting kinase, CIT/
CTRO)
0 13 0 0 Gai et al. (2011)
Other Proteins
Nucleophosmin, NPM1 13 20 7 3
Nucleolin, NCL 5 22 0 0
60S ribosomal protein L4, RPL4 5 27 0 0
60S ribosomal protein L7, RPL7 2 20 4 7
Total specific spectral counts, minus any background counts observed in EGFP-only samples, for the 43 most abundant (of 265 total) proteins that coisolated 
in triplicate analyses with EGFP-tagged human supervillin (SVIL) or anillin (ANLN) and anti-GFP nanobody affinity beads from M-phase–enriched (M phase) and 
unsynchronized HeLa cells (unsynchronized). Only proteins represented by >20 specific peptides, e.g., an average of ∼7 peptides/experiment, are shown. Citron 
Rho-interacting kinase, in italics, is included because of its documented interaction with anillin. References cite previously documented interactions.
TABLE 1: Most abundant specific interactors with GFP-tagged supervillin and anillin. Continued
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under fixation conditions that reduce the cortical signal and that 
supervillin residues 676–1009 bind directly to PRC1. In addition, 
cleavage furrows became elongated in the absence of the MHC/L-
MLCK–interacting supervillin N-terminus or after mutation to ala-
nine of Ser-238, a residue that is phosphorylated by polo-like kinase 
1 (PLK1), a PRC1-binding partner and cytokinesis regulator (Hu 
et al., 2012). These supervillin mutations reduced pMRLC localiza-
tion at the furrow during ingression (Hasegawa et al., 2013). These 
results are consistent with our observations that the loss of supervil-
lin decreases the proportion of total MHC at the furrow during ana-
phase II and telophase and affects the proportion of furrow pMRLC 
during early anaphase and bridge formation. The results of Hase-
gawa et al. (2013) also may explain the failure of bSV, which naturally 
has an alanine at position 238, to substitute for human supervillin in 
rescue experiments and imply that not all functional regulatory sites 
in the supervillin N-terminus are conserved across species.
Supervillin is likely to be differentially important for cytokinesis in 
vertebrate cells, as opposed to other organisms. First, although a 
sequence 70% identical (85% similar) to the MHC-binding site in 
human supervillin is found in sea urchin supervillin (XP_784024.3), 
no sequences similar to those implicated in L-MLCK binding (resi-
dues 1–10 and 23–101) are present. This suggests a different regula-
tory mechanism in sea urchin, the only organism in which MLCK is 
known to play a major role in activating myosin II during cell division 
(Lucero et al., 2006; Uehara et al., 2008). Second, the MHC- and L-
MLCK–binding N-terminal sequences identified here are absent 
from fly and worm supervillin homologues (CG33232; viln-1/
C10H11.1), potentially explaining why anillin knockdown in 
Drosophila Kc167 cells displays more penetrance than is observed 
in HeLa cells (Straight et al., 2005). Taken together, these observa-
tions suggest that supervillin may act as a genetic buffer for anillin 
function to ensure the fidelity of cytokinetic bridge formation and 
midbody formation in vertebrates.
We conclude that the myosin II–binding capability of supervillin 
is required for high-fidelity cell division and that supervillin helps to 
recruit and activate myosin II in the furrow cortex, especially during 
the bridge stage of cytokinesis. The identities of supervillin and anil-
lin interactors suggest that each may scaffold the central spindle 
with the furrow cortex, with supervillin associating with myosin II, 
unbranched actin filaments, and signaling proteins, many of which 
play important roles in interphase processes, including cell migra-
tion and membrane trafficking. Thus, during both interphase and 
cytokinesis, supervillin integrates dynamic processes involving mem-
brane signaling cascades, vesicle trafficking, microtubule-rich struc-
tures, and the actin- and myosin II–associated membrane cortex.
MATERIALS AND METHODS
Cell culture
Adherent HeLa S3 Tet-Off (Clontech, Mountain View, CA) and COS7 
cells were grown as described previously (Smith et al., 2010). HeLa 
S3 Tet-Off cells stably expressing a GFP fusion to human supervillin, 
nonmuscle isoform 1 (Fang and Luna, 2013), latently discovered to 
bear a point mutation (K923E), were cultured in the HeLa medium. 
All experiments were performed in six-well culture dishes containing 
22-mm2 coverslips, except for production of extracts used in GST 
pull downs and GFP nanobody affinity isolations (see later descrip-
tions). All cultures were grown at 37°C in 5% CO2.
Antibodies
For immunoblotting, rabbit anti-supervillin (H340; Nebl et al., 2002; 
Oh et al., 2003) was used at 1:1000. Rabbit antibody against amino 
acids 417–687 in human anillin was a kind gift from Michael Glotzer 
somewhat later than, cell division defects caused by loss of anillin 
from human cells (Straight et al., 2005; Zhao and Fang, 2005); and 
that supervillin synergizes with anillin to regulate myosin II at the fur-
row. In supervillin-knockdown cells, some cortical MHC redistributes 
away from the furrow, beginning in late anaphase, whereas pMRLC 
distribution is aberrant only in early anaphase and at the bridge 
stage. Of interest, Rab21-associated integrin trafficking, a process 
facilitated by supervillin (Fang et al., 2010), is similarly required for 
both initial myosin activation signaling and membrane recruitment 
to the ends of the invaginating furrow (Pellinen et al., 2008). Because 
anillin localizes normally in supervillin-knockdown cells until bridge 
formation, it is apparently sufficient for myosin II activation at the 
furrow during late anaphase and telophase. In supervillin-knock-
down cells, the overexpression and redistribution of anillin to the 
bridge ends and the apical cortices of nascent daughter cells, which 
are characteristic localizations for supervillin (Smith et al., 2010), may 
allow anillin to partially compensate for supervillin depletion from 
cytokinetic bridges. Functional cross-talk between supervillin and 
anillin is further supported by the mislocalization of supervillin in 
anillin-knockdown cells and the more-than-additive effects observed 
after double knockdowns of both proteins. Taken together, these 
results suggest that anillin and supervillin coordinate during the 
initial activation of myosin II in the anaphase cortex, anillin plays the 
primary role in myosin activation during later anaphase and telo-
phase, and supervillin is required primarily for cortical constriction or 
membrane trafficking during bridge elongation or closure.
Proteomic identifications of supervillin and anillin interactors 
support the presence of separate functional pathways that coordi-
nately regulate cytokinesis. Supervillin and anillin apparently do not 
interact directly, but each binds to both MHC and F-actin. Not all 
reported binding partners were identified in the affinity isolates, 
possibly due to insolubility of very large complexes or the loss of 
proteins with lower avidities. Nonetheless, many interactors with 
signaling capabilities show specificity for one protein or the other. 
These results suggest overlap of function between supervillin and 
anillin at the level of myosin II recruitment and activation, with each 
protein playing a key role at the cortex at different stages of cell divi-
sion. The greater association of actin-binding proteins with supervil-
lin, especially the abundance of stress fiber–associated proteins, is 
reminiscent of observations in Drosophila cells, in which unbranched 
actin filaments are required for continued myosin II localization at 
the furrow (Dean et al., 2005). The number of supervillin-associated 
unconventional myosins raises questions about whether their motor 
or actin-binding activities contribute to membrane trafficking or cor-
tical tension during the later stages of bridge narrowing.
The interactions of supervillin and anillin with different central 
spindle and signaling proteins suggest that each can promote scaf-
folding or signaling between the furrow cortex and the central spin-
dle (Figure 5A). Furthermore, the second region of supervillin im-
portant for normal cell division (SV-831–1281) contains the 
KIF14-interaction site (Smith et al., 2010) and potentially a binding 
site for PRC1 (Hasegawa et al., 2013), both of which are required for 
central spindle assembly (Carleton et al., 2006; Neef et al., 2007; 
Shrestha et al., 2012). The interaction of KIF14 with citron kinase 
(Gruneberg et al., 2006; Watanabe et al., 2013), which coisolates 
with anillin (Table 1; Gai et al., 2011), suggests that supervillin and 
anillin could each link the cortex with separate-but-interacting com-
ponents of the central spindle.
While this work was in revision, another report also proposed 
supervillin as a molecular link between myosin II activation and cen-
tral spindle function (Hasegawa et al., 2013). These researchers 
showed that supervillin epitopes are found at the central spindle 
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were created by PCR using EGFP-bSV-1–830 as template. The 
resulting fragments were then ligated in-frame into either the 
pEGFP-C1 or -N3 vector (Clontech). EGFP-bSV-72–174 and bSV-
93–174-EGFP were created by converting residues R72 and S73 in 
bSV-1–174 to a BglII restriction site, followed by digestion with BglII 
(New England Biolabs) and religation. All primers for point muta-
genesis and PCR are listed in Supplemental Table S1.
Targeted alanine mutations were introduced into bSV-1–174 and 
hSV-1–330 using the QuikChange kit as described and primers 
listed in Supplemental Table S1. To mutate a total of four residues in 
bSV-1–11 and bSV-33–51, a second set of primers was used to intro-
duce additional mutations into bSV-1–174-R9A,R10A and bSV-1–
174-M43A,R44A. EGFP-bSV-1–174 mutants were restriction di-
gested with NheI and PvuI (New England Biolabs) and cloned into 
the corresponding restriction sites in EGFP-bSV-1–1792. EGFP-
hSV-1–330 mutants were restriction digested with NheI-HF and 
BstEII-HF (New England Biolabs) and ligated into the corresponding 
sites in EGFP-hSV-1–1788. All constructs and mutations were veri-
fied by sequencing.
Transfections and protein extractions
For protein knockdowns, HeLa cells were reverse transfected with 
20 nM total dsRNA (20 nM control, or 10 nM each of control and 
either supervillin or anillin dsRNAs) and 5 μl of Lipofectamine 
RNAiMAX (Life Technologies), according to the manufacturer’s in-
structions. In rescue experiments, 4 μl of Lipofectamine 2000 (Life 
Technologies) was used to reverse transfect dsRNAs (20 nM total 
concentration) and plasmid DNA (1.5–4.0 μg) together, and cells 
were grown on coverslips coated with bovine fibronectin (Sigma-
Aldrich, St. Louis, MO; Smith et al., 2010). After transfection, cells 
were incubated for 48 h before fixation with 4% paraformaldehyde 
or extraction with RIPA buffer containing protease inhibitors (Smith 
et al., 2010). To produce extracts for GST pull-down experiments, 
HeLa cells were plated in 6-cm dishes and incubated overnight be-
fore transfection using Lipofectamine 2000 and either EGFP or 
EGFP-tagged BSV-1–174 deletion and mutation constructs. After 
24 h of expression, cells were extracted with RIPA buffer lacking SDS 
and clarified by centrifugation at 16,000 × g for 15 min at 4°C (Smith 
et al., 2010). Each 6-cm dish extract was divided for use in pull 
downs with both GST–myo-S2 and GST–L-MLCK-6Ig.
For visualization of proteins during cell division, cells were syn-
chronized at the G2/M transition by incubation for 20 h with 10 μM 
RO-3306 (Enzo Life Sciences, Farmingdale, NY), a reversible Cdk1 
inhibitor (Vassilev, 2006). Cells were released by rinsing three times 
with D-PBS (Life Technologies) and then incubated at 37°C with 
fresh medium for 90–105 min before fixation in 4% paraformalde-
hyde and staining. To screen for dominant-negative effects of EGFP-
bSV proteins on cell division, cells were reverse transfected as de-
scribed, incubated overnight, synchronized with RO-3306, and then 
released for 4–18 h before fixation and staining.
COS7 cells were seeded on coverslips for 24 h before being 
transfected with 1–1.5 μg of EGFP-tagged constructs and 10 μl Ef-
fectene transfection reagent (Qiagen, Valencia, CA). Cells were then 
incubated for 24 h before fixation with 4% paraformaldehyde and 
staining.
Imaging and equatorial:polar ratio determination
Cells were imaged using an Axioskop fluorescence microscope with 
Plan-NeoFluor objectives (Carl Zeiss Microscopy, Thornwood, NY), 
as described previously (Smith et al., 2010). Protein localizations in 
dividing HeLa cells and myosin II punctae in COS7 cells were 
imaged using a 100× (numerical aperture [NA] 1.3) oil immersion 
(University of Chicago; Piekny and Glotzer, 2008) and used at 1:5000. 
Mouse monoclonal anti-actin (C4; Millipore, Temecula, CA) was 
used at 1:3000. Rabbit monoclonal anti-GFP (D5.1; Cell Signaling, 
Beverly, MA) was used at 1:1000. Rabbit polyclonal anti–myosin 
IIA (Covance, Princeton NJ) was used at 1:10,000. Horseradish 
peroxidase–conjugated donkey anti-mouse and anti-rabbit anti-
bodies (Jackson ImmunoResearch, West Grove, PA) were used at 
1:20,000.
For immunofluorescence, HeLa cells were stained with mouse 
monoclonal anti-pMRLC (Ser-19; 1:200; Cell Signaling), rabbit anti-
anillin (1:1500), or rabbit polyclonal anti–myosin IIA (1:200; Cova-
nce). COS7 cells were stained with rabbit polyclonal anti-myosin IIB 
(1:100; Covance). Rabbit polyclonal anti-EGFP (1:1000; Abcam, 
Cambridge, MA) was used to enhance the EGFP-supervillin signal in 
the stable HeLa cell line (Smith et al., 2010). Secondary antibodies 
were goat anti-rabbit or anti-mouse Alexa Fluor 488 conjugates 
(HeLa) and goat anti-rabbit Alexa Fluor 568 (COS7; Life Technolo-
gies, Grand Island, NY). Actin and DNA were visualized using Alexa 
Fluor 568–phalloidin (Life Technologies) and Hoechst, respectively.
RNA interference
Stealth (Life Technologies) duplex sequence for SV-6016-6040 
(SVKD-2) was described previously (Smith et al., 2010); this dsRNA 
targets a 3′-UTR sequence absent from EGFP-supervillin. The 
following Stealth dsRNA sequences also were used: 5′-GAACU-
AUG AAGG ACCACCAGAGAUA (scrambled control) and 5′-GAA-
GAU AUCGAAGCCAGACCAGAUA against a coding sequence 
present in both endogenous and EGFP-tagged human supervillin 
(SVKD-1; SV-2473-2497). 5′-ACGAAAGGGUUUGUGCCAAUAUUCA 
(AnilKD-1; ANLN-3473-3497) and 5′-CGUGAUAUGACUUGUUAC-
UAGGGUA (AnilKD-2; ANLN-3800-3824) were used to knock down 
anillin.
Plasmids
The nonmuscle myosin IIA-S2 region was subcloned from 6xHis-
NMIIAS2 vector, a kind gift from Mitsuo Ikebe (University of Massa-
chusetts Medical School), and transferred into pGEX-6P-3 (GE 
Healthcare Life Sciences, Piscataway, NJ) by restriction digest using 
EcoRI and XhoI (New England Biolabs, Beverly, MA). A vector en-
coding a GST fusion with the six Ig domains of the L-MLCK N-termi-
nus, amino acids 2–867 (L-MLCK-6Ig), was a kind gift from Anne 
Bresnick (Albert Einstein College of Medicine; Dulyaninova et al., 
2004). EGFP-hSV was generated by PCR (Pope et al., 1998) and 
ligated into pEGFP-C2 between EcoRI and XbaI in two steps by 
Zhiyou Fang (University of Massachusetts Medical School; Fang 
and Luna, 2013). First, a 3′ EcoRV/XbaI fragment was ligated into 
pEGFP-C2 digested with SmaI and XbaI. This vector was then di-
gested with EcoRI and ligated with an EcoRI fragment containing 
the hSV 5′ sequence. EGFP (Clontech), EGFP-bSV, bSV-1–171-EGFP, 
EGFP-bSV-171–1792, EGFP-bSV-1–830, EGFP-bSV-831–1281, 
EGFP-bSV-1–1009, EGFP-bSV-1010–1792, EGFP-bSV-831–1792, 
EGFP-bSV-1–342, and bSV-1–174-EGFP were described previously 
(Wulfkuhle et al., 1999; Chen et al., 2003; Takizawa et al., 2007). 
EGFP-bSV-1–174 was created by converting residue G175 in EGFP-
bSV1–342 (Wulfkuhle et al., 1999) to a stop codon using the 
QuikChange Site-Directed Mutagenesis kit (Agilent Technologies, 
Santa Clara, CA). Two C-terminal deletion constructs were made by 
restriction digestion of EGFP-bSV-1–342. Digestion with BamHI 
(New England Biolabs) and religation resulted in EGFP-bSV-1–127; 
digestion with XhoI (New England Biolabs) and religation produced 
EGFP-bSV-1–101. EGFP-bSV-1–23 was created by converting resi-
due L24 to a stop codon. EGFP-bSV-11–174 and bSV-11–174-EGFP 
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analysis by liquid chromatography and tandem mass spectrometry 
(LC-MS/MS).
In-gel digestion
Samples for in-gel digestion were run ∼1.5 cm into the resolving 
area of 10% minigels and stained with a ProteoSilver Silver Stain Kit 
(Sigma-Aldrich). Protein-containing regions were excised, 
destained, and cut into 1 × 1 mm pieces. Gel pieces were placed 
in 1.5-ml microcentrifuge tubes with 1 ml of water for 1 h. The 
water was removed, and 125 μl/tube 250 mM ammonium bicar-
bonate was added. Disulfide bonds were reduced by adding 
25 μl/tube 45 mM 1,4-dithio-d-threitol and incubating for 30 min at 
50°C. Samples were cooled to room temperature and alkylated for 
30 min with 25 μl/tube 100 mM iodoacetamide. Gel slices were 
washed twice with 1-ml aliquots of water and incubated at room 
temperature for 1 h with 1 ml/tube of a 50:50 mixture of 50 mM 
ammonium bicarbonate:acetonitrile. This solution was replaced with 
200 μl/tube of acetonitrile, at which point the gel slices turned 
opaque white. After removal of acetonitrile, the gel slices were fur-
ther dried in a Savant SpeedVac (Thermo Scientific, Asheville, NC). 
Gel slices were rehydrated in 75 μl/tube of 2 ng/μl trypsin (Sigma-
Aldrich) in 0.01% ProteaseMAX Surfactant (Promega, Madison, WI) 
and 50 mM ammonium bicarbonate. Additional aliquots of 50 mM 
ammonium bicarbonate were added, as necessary, to fully sub-
merge the gel slices. Samples were incubated for 21 h at 37°C. 
Supernatants were removed to separate 1.5-ml microcentrifuge 
tubes. Gel slices were extracted further with 100 μl/tube of 80:20 
acetonitrile:1% formic acid. Extracts for each sample were com-
bined, and the tryptic peptides were dried in a SpeedVac.
LC-MS/MS
Dried tryptic peptides were dissolved in 25 μl of 0.1% trifluoroacetic 
acid and 5% acetonitrile, and a 3-μl aliquot was directly injected 
onto a custom-packed trap column (2 cm × 100 μm C18). Peptides 
were eluted and sprayed from a custom-packed emitter (25 cm × 
75 μm C18) with a linear gradient from 100% solvent A (0.1% formic 
acid, 5% acetonitrile) to 35% solvent B (0.1% formic acid, acetonitrile) 
in 90 min at a flow rate of 300 nl/min on a Proxeon Easy nanoLC 
system directly coupled to a LTQ Orbitrap Velos mass spectrometer 
(Thermo Scientific). Data-dependent scans were acquired according 
to a scheme in which full MS scans from 350 to 2000 m/z were ac-
quired in the Orbitrap Velos at a resolution of 60,000, followed by 
10 MS/MS scans acquired in the LTQ ion trap instrument. The raw 
data files were processed with Extract_ MSN (Thermo Scientific) into 
peak lists and then searched against the Human index of the 
SwissProt database using the Mascot Search engine, version 2.4 
(Matrixsciences, London, United Kingdom). Parent mass tolerances 
were set to 10 ppm, and fragment mass tolerances were set to 
0.5 Da. The variable modifications of acetyl (protein N-terminus), 
pyro glutamic for N-terminal glutamine, carbamidomethylation of 
cysteine, and oxidation of methionine were used. Mascot search re-
sults were loaded into Scaffold4 software (Proteome Software, Port-
land, OR) for comparisons of sample results. Cosedimenting pro-
teins were screened using conservative parameters, with a positive 
identification requiring a protein threshold of 99% and a minimum of 
two peptides per protein, with a peptide threshold of 95%. The es-
timated Prophet false discovery rate at these settings is <0.4%.
Proteins present in EGFP-only affinity isolates at spectral count 
levels ≥50% of the number of peptides identified in EGFP-hSV or 
EGFP-anillin fractions were defined as contaminants and eliminated; 
these proteins are listed in Supplemental Table S2. The most abun-
dant interactors are presented in Table 1. All identified proteins 
objective. Numbers of binucleated/multinucleated HeLa cells were 
assayed using a 40× (NA 0.9) objective lens, and representative 
overviews for Figure 5B were obtained with a 25× (NA 0.8) objec-
tive. Images were uniformly adjusted for brightness and contrast, 
and merged images were assembled with Photoshop (Adobe, San 
Jose, CA).
Average signal intensities at the equatorial and polar cortices 
were determined using a modification of the method of Robinson 
et al. (2002). The polygon tool in ImageJ (National Institutes of 
Health, Bethesda, MD) was used to select areas with widths of 
∼0.4 μm that covered the cortex signal along the regions of the cell 
indicated in Figures 2 and 7. Mean signal intensities for these boxes 
were obtained by using the Measure function under the Analyze 
menu with area, mean signal intensity, and SD selected for output. 
Measurements were made for each pole and each side of the furrow 
(Figure 2), which were then averaged using Excel (Microsoft, 
Redmond, WA) before calculating the ratio of equatorial to polar 
signal. For anillin localization at the midbody (Figure 7), signal inten-
sities along the daughter cell cortices proximal to the midbody were 
analyzed and averaged as before, but the midbody signal itself was 
taken as one measurement. InStat software, version 3 (GraphPad 
Software, San Diego, CA), was used to calculate means and SD and 
perform statistical tests.
GST pull down and SDS–PAGE
Fusion proteins were made using Rosetta DE3 pLysS competent 
Escherichia coli (EMD4Biosciences, La Jolla, CA), as previously de-
scribed (Swaffield and Johnston, 2001; Chen et al., 2003; Smith 
et al., 2010). GST pull-down assays were performed as previously 
described (Smith et al., 2010). HeLa cell lysates were separated on 
5–15% gradient SDS–PAGE gels and transferred to Protran nitrocel-
lulose (Whatman, Dassel, Germany) to confirm knockdown of super-
villin and anillin proteins and expression of EGFP-SV. Extracts con-
taining bSV-1–174 proteins were run on 10% SDS–PAGE gels. Blots 
were visualized using either Supersignal WestPico or WestFemto 
ECL reagents (Thermo Scientific, Rockford, IL) on a Kodak Image 
Station (Eastman Kodak, Rochester, NY). Protein band densities 
were obtained using Kodak Molecular Imaging Software, version 
4.0 (Eastman Kodak) and ratios calculated using Excel.
GFP nanobody affinity isolations
Protein affinity isolations were performed using a GFP nanobody 
covalently bound to magnetic beads. Isolations were performed in 
triplicate, with replicates carried out on separate days. HeLa cells 
from a subconfluent T-75 flask were split into three 10-cm dishes 
and incubated overnight. Cells were then transfected using Lipo-
fectamine 2000 and 13 μg of EGFP, EGFP-anillin, or EGFP-hSV and 
incubated for 24 h before extraction. To enrich for dividing cells, 
plates were incubated for 3 h after transfection and then treated 
with 10 μM RO-3306 (Enzo Life Sciences), as described. Cells were 
released from synchronization for 100 min before extraction. Cells 
were extracted with 1 ml of RIPA buffer with protease inhibitors but 
lacking SDS (Smith et al., 2010). Ten microliters (per extract) of anti-
GFP nanobody-conjugated beads (Domanski et al., 2012) were 
washed three times in cold RIPA buffer lacking SDS before the ad-
dition of 900 μl of cleared lysate. Strong magnets were used at 
each step to separate the beads from the lysate and washes. After 
incubation for 1 h at 4°C with rotation, the beads were transferred 
to a fresh tube and washed three times with ice-cold RIPA buffer 
lacking SDS. Proteins were eluted from the magnetic beads with 
2% SDS and run on either 5–15% acrylamide SDS gels (Laemmli, 
1970) for silver staining or 10% SDS–PAGE for in-gel digestion and 
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meeting the cut-off parameters and the spectral counts from each 
experiment, including background counts, are reported in Supple-
mental Tables S3 and S4.
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SUPPLEMENTARY MATERIAL 
Supplemental Table S1 (PDF).  Primers used for PCR and point mutagenesis.  Construct names are in 
the first column; sense and anti-sense primers are in columns 2 and 3, respectively.   Underlined bases 
indicate imbedded restriction sites used for cloning.  Italics indicate mutated bases.  The asterisk (*) 
denotes that this primer pair was used in a second round of mutagenesis with either bSV-R9A,R10A or 
bSV-M43A,R44A as a template. 
 
Supplemental Table S2 (PDF).  Proteins eliminated as contaminants in co-isolates with GFP nanobodies 
attached to magnetic beads.  These proteins were present in EGFP-only affinity isolates at spectral count 
levels ≥ 50% of the number of peptides identified in EGFP-hSV or EGFP-anillin fractions. 
 
Supplemental Table S3 (MS Excel).  All proteins identified in triplicate GFP nanobody affinity isolates 
using lysates from M-Phase enriched HeLa cells expressing EGFP, EGFP-hSV, or EGFP-anillin.  Total 
spectral counts of identified peptides shown for each replicate.  Positive identifications were made as 
described in the legend for Table 1. 
 
Supplemental Table S4 (MS Excel).  All proteins identified in triplicate GFP nanobody affinity isolates 
using lysates from unsynchronized HeLa cells expressing EGFP, EGFP-hSV, or EGFP-anillin.  Positive 
identifications were made as described in the legend for Table 1. 
 
Supplemental Figure S1.  Representative micrographs of interphase cells reported in Figure 1G.  Cells were 
transfected with the indicated EGFP-tagged bovine supervillin constructs for 48 h and evaluated for 
bi/multinucleate phenotype.  Phase images (a, d, g, j, m, p, s, v, y), EGFP (b, e, h, k, n, q, t, w, z), and DNA (c, 
f, i, l, o, r, u, x, aa).  Nuclei of cells expressing EGFP-tagged proteins are indicated with white arrowheads (c, f, 
i, l, o, r, u, x, aa).  Bar = 20 µm. 
 
Supplemental Figure S2.  Representative localizations of EGFP-tagged supervillin deletion constructs in 
dividing cells.  EGFP (a-d), bSV-1-171-EGFP (e-h), EGFP-bSV-171-1792 (i-l), EGFP-bSV-1-830 (m-p), 
EGFP-bSV-1-1009 (q-t), EGFP-bSV-1010-1792 (u-x), and EGFP-bSV-831 - 1281 (y-b’).  EGFP (green 
in merges) shown in a, e, i, m, q, u, and y.  Actin (red in merges) shown in b, f, j, n, r, v, and z.  DNA 
(blue in merges), c, g, k, o, s, w, and a’.  Merged images in d, h, l, p, t, x, and b’.  Phase images in d’, h’, 
l’, p’, t’, x’, b”.  Bar = 10 µm. 
 
Supplemental Figure S3.  Representative micrographs showing the effects of deletion mutations within bSV-
1-174-EGFP on the ability of this protein to form myosin II punctae after overexpression in COS7 cells. 
EGFP-tagged full-length bSV-1-174 causes hyperactivation of co-localizing myosin II filaments into stable 
punctae with L-MLCK (Chen et al., 2003; Takizawa et al., 2007).  Transfected COS7 cells were stained for 
myosin IIB heavy chain (MHC-IIB; a, d, g, j, m, p, s, v, y; red in merges) and evaluated for myosin II punctae, 
indicated at right by (+) punctae formed, (+/-) incomplete conversion, or (-) no punctae. EGFP constructs (b, e, 
h, k, n, q, t, w, z; green in merges) are: (b) EGFP alone, (e) bSV-1-174-EGFP, (h) EGFP-bSV-1-174, (k) 
EGFP-bSV-1-127, (n) EGFP-bSV-1-101, (q) EGFP-bSV-1-23, (t) bSV-11-174-EGFP, (w) EGFP-bSV-72-174, 
and (z) bSV-93-174-EGFP.  Merged images (c, f, i, l, o, r, u, x, a’).  Bar, 20 µm. 
 
Supplemental Figure S4.  Representative micrographs showing the effects of point mutations within bSV-1-
174-EGFP on the ability of this protein to form hyperactivated myosin II punctae after overexpression in 
COS7 cells.  Transfected COS7 cells were stained for myosin II heavy chain (a, d, g, j, m, p, s, v, y; red in 
merges) and evaluated for myosin II-punctae, indicated at right by (+) punctae formed, (+/-) incomplete 
conversion, and (-) no punctae. EGFP constructs (b, e, h, k, n, q, t, w, z; green in merges) are: (b) bSV-1-174-
K4A,R6A,R9A,R10A-EGFP; (e) bSV-1-174-R9A,R10A-EGFP; (h) bSV-1-174-E36A,E37A-EGFP; (k) bSV-
1-174-R41A,Y42A-EGFP; (n) bSV-1-174-M43A,R44A-EGFP; (q) bSV-1-174-R107A,Y108A-EGFP; (t) 
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bSV-1-174-R112A,R113A-EGFP; (w) BSV-1-174-EGFP-E127A,D129A; (z), BSV-1-174-EGFP-
R140A,K141A.  Merged images (c, f, i, l, o, r, u, x, a’).  Bar, 20 µm. 
 
Supplemental Figure S5.  Identification of supervillin sequences required for L-MLCK interaction. (A, B, C, 
D) Bound and unbound deletion and point mutants of EGFP-tagged bSV 1-174, as indicated, in pulldown 
experiments with the GST-tagged L-MLCK N-terminus.  Blots were probed with anti-GFP; Ponceau staining 
of blots with bound proteins shows equal loading of the GST-tagged bait protein.  Ratios of bound:unbound 
EGFP signal, normalized to 1-174-EGFP ratio, are shown.  Ratios < 0.5 were considered to indicate reduction 
in binding to L-MLCK.  N ≥ 2.  (E) Immunoblot of bound and unbound fractions probed for MHC-IIA in cell 
lysates.  Input lysate (lane 1), EGFP (lane 2), bSV-1-174-EGFP (lane 3), bSV-1-174-K4A,R6A,R9A,R10A-
EGFP (lane 4), bSV-1-174-R9A,R10A-EGFP (lane 5).  Bound and unbound samples were probed on the same 
blot; Ponceau staining shows GST-L-MLCK-6Ig in bound fractions to verify loading. 
 
 
  
 
 
 
Supplemental Table S1 (PDF).  Primers used for PCR and point mutagenesis.  Construct names are in 
the first column; sense and anti-sense primers are in columns 2 and 3, respectively.   Underlined bases 
indicate imbedded restriction sites used for cloning.  Italics indicate mutated bases.  The asterisk (*) 
denotes that this primer pair was used in a second round of mutagenesis with either bSV-R9A,R10A or 
bSV-M43A,R44A as a template. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Table S2.  Proteins eliminated as contaminants in co-isolates with GFP nanobodies 
attached to magnetic beads.  These proteins were present in EGFP-only affinity isolates at spectral count 
levels ≥ 50% of the number of peptides identified in EGFP-hSV or EGFP-anillin fractions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S1.  Representative 
micrographs of interphase cells reported 
in Figure 1G.  Cells were transfected with 
the indicated EGFP-tagged bovine 
supervillin constructs for 48 h and 
evaluated for bi/multinucleate phenotype.  
Phase images (a, d, g, j, m, p, s, v, y), 
EGFP (b, e, h, k, n, q, t, w, z), and DNA 
(c, f, i, l, o, r, u, x, aa).  Nuclei of cells 
expressing EGFP-tagged proteins are 
indicated with white arrowheads (c, f, i, l, 
o, r, u, x, aa).  Bar = 20 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S2.  
Representative localizations of 
EGFP-tagged supervillin 
deletion constructs in dividing 
cells.  EGFP (a-d), bSV-1-
171-EGFP (e-h), EGFP-bSV-
171-1792 (i-l), EGFP-bSV-1-
830 (m-p), EGFP-bSV-1-
1009 (q-t), EGFP-bSV-1010-
1792 (u-x), and EGFP-bSV-
831 - 1281 (y-b’).  EGFP 
(green in merges) shown in a, 
e, i, m, q, u, and y.  Actin 
(red in merges) shown in b, f, 
j, n, r, v, and z.  DNA (blue 
in merges), c, g, k, o, s, w, 
and a’.  Merged images in d, 
h, l, p, t, x, and b’.  Phase 
images in d’, h’, l’, p’, t’, x’, 
b”.  Bar = 10 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S3.  
Representative micrographs 
showing the effects of deletion 
mutations within bSV-1-174-
EGFP on the ability of this 
protein to form myosin II punctae 
after overexpression in COS7 
cells. EGFP-tagged full-length 
bSV-1-174 causes 
hyperactivation of co-localizing 
myosin II filaments into stable 
punctae with L-MLCK (Chen et 
al., 2003; Takizawa et al., 2007).  
Transfected COS7 cells were 
stained for myosin IIB heavy 
chain (MHC-IIB; a, d, g, j, m, p, 
s, v, y; red in merges) and 
evaluated for myosin II punctae, 
indicated at right by (+) punctae 
formed, (+/-) incomplete 
conversion, or (-) no punctae. 
EGFP constructs (b, e, h, k, n, q, 
t, w, z; green in merges) are: (b) 
EGFP alone, (e) bSV-1-174-
EGFP, (h) EGFP-bSV-1-174, (k) 
EGFP-bSV-1-127, (n) EGFP-
bSV-1-101, (q) EGFP-bSV-1-23, 
(t) bSV-11-174-EGFP, (w) 
EGFP-bSV-72-174, and (z) bSV-
93-174-EGFP.  Merged images 
(c, f, i, l, o, r, u, x, a’).  Bar, 20 
µm. 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S4.  
Representative 
micrographs showing the 
effects of point mutations 
within bSV-1-174-EGFP 
on the ability of this 
protein to form 
hyperactivated myosin II 
punctae after 
overexpression in COS7 
cells.  Transfected COS7 
cells were stained for 
myosin II heavy chain (a, 
d, g, j, m, p, s, v, y; red in 
merges) and evaluated for 
myosin II-punctae, 
indicated at right by (+) 
punctae formed, (+/-) 
incomplete conversion, 
and (-) no punctae. EGFP 
constructs (b, e, h, k, n, q, 
t, w, z; green in merges) 
are: (b) bSV-1-174-
K4A,R6A,R9A,R10A-
EGFP; (e) bSV-1-174-
R9A,R10A-EGFP; (h) 
bSV-1-174-E36A,E37A-
EGFP; (k) bSV-1-174-
R41A,Y42A-EGFP; (n) 
bSV-1-174-M43A,R44A-
EGFP; (q) bSV-1-174-
R107A,Y108A-EGFP; (t) 
bSV-1-174-
R112A,R113A-EGFP; (w) 
BSV-1-174-EGFP-
E127A,D129A; (z), BSV-
1-174-EGFP-
R140A,K141A.  Merged 
images (c, f, i, l, o, r, u, x, 
a’).  Bar, 20 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S5.  Identification of supervillin sequences required for L-MLCK interaction. (A, 
B, C, D) Bound and unbound deletion and point mutants of EGFP-tagged bSV 1-174, as indicated, in 
pulldown experiments with the GST-tagged L-MLCK N-terminus.  Blots were probed with anti-GFP; 
Ponceau staining of blots with bound proteins shows equal loading of the GST-tagged bait protein.  
Ratios of bound:unbound EGFP signal, normalized to 1-174-EGFP ratio, are shown.  Ratios < 0.5 were 
considered to indicate reduction in binding to L-MLCK.  N ≥ 2.  (E) Immunoblot of bound and unbound 
fractions probed for MHC-IIA in cell lysates.  Input lysate (lane 1), EGFP (lane 2), bSV-1-174-EGFP 
(lane 3), bSV-1-174-K4A,R6A,R9A,R10A-EGFP (lane 4), bSV-1-174-R9A,R10A-EGFP (lane 5).  
Bound and unbound samples were probed on the same blot; Ponceau staining shows GST-L-MLCK-6Ig 
in bound fractions to verify loading. 
